Advertisement

Kopf-Hals-Tumoren

  • D. Thönnessen
  • H. Hof
  • R. Krempien
  • M. W. Münter
  • M. Bischof
  • K. K. Herfarth
  • D. Schulz-Ertner
  • K. Fleckenstein
Chapter

Zusammenfassung

Der Altersgipfel beim Nasopharynxkarzinom (NPC) liegt im 6. Lebensjahrzehnt. Die geschlechtsspezifische Verteilung beträgt 2,2 : 1 (Männer : Frauen). Die Inzidenz liegt bei 0,5 pro 100 000.

Literatur

Zu Nasopharynxkarzinom

  1. Al-Sarraf M, LeBlanc M, Giri PG et al. (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310–1317PubMedGoogle Scholar
  2. Beckmann G, Flentje M (2003) Wo stehen wir in der Behandlung des Nasopharynxkarzinoms? Strahlenther Onkol 179:283–291PubMedGoogle Scholar
  3. Cellai E, Olmi P, Chiavacci A et al. (1990) Computed tomography in nasopharyngeal carcinoma: Part II: Impact on survival. Int J Radiat Oncol Biol Phys 19(5):1177–1182PubMedGoogle Scholar
  4. Chan AT, Teo PM, Leung TW, Lee WY, Yeo W, Choi PH, Johnson PJ (1995) A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33:569–577PubMedGoogle Scholar
  5. Chan AT, Teo PM, Johnson PJ (1998) Controversies in the management of locoregionally advanced nasopharyngeal carcinoma. Curr Opin Oncol 10:219–225PubMedGoogle Scholar
  6. Chang JT, See LC, Liao CT et al. (1998) Early stage nasopharyngeal carcinoma: Radiotherapy dose and time factors in tumour control. Jpn J Clin Oncol 28(3):207–213PubMedGoogle Scholar
  7. Cheung M, Chan AS, Law SC, Chan JH, Tse VK (2000) Cognitive function of patients with or without temporal lobe radionecrosis. Arch Neurol 57:1347–1352PubMedGoogle Scholar
  8. Chi KH, Chang YC, Guo WY, Leung MJ et al. (2002) A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Rad Oncol Biol Phys 52 (5):1238–1244Google Scholar
  9. Chua DTT, Sham JST, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S et al. (1998) Preliminary report of the Asian-Oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 83:2270–2283PubMedGoogle Scholar
  10. Daoud J, Ben Salah H, Kammoun W, Ghorbel A, Frikha M, Jlidi R et al. (2000) Radiation-induced glioblastoma and myxoma after treatment for undifferentiated carcinoma of the nasopharynx. Cancer Radiother 4:469–472PubMedGoogle Scholar
  11. Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W, Wagner H, Ensley JF Cooper JS. (2013) Long-term results of rtog 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31:845–852Google Scholar
  12. Fuchs S, Rödel C, Brunner T, Iro H, Niedobitek, Sauer R, Grabenbauer GG (2003) Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma. Onkologie 26:12–18PubMedGoogle Scholar
  13. Hughes PJ, Scott PM, Kew J, Cheung DM, Leung SF, Ahuja AT et al. (2000) Dysphagia in treated nasopharyngeal cancer. Head Neck 22:393–397PubMedGoogle Scholar
  14. Geara FB, Sanguineti G, Tucker SL et al. (1997) Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol 43(1):53–61PubMedGoogle Scholar
  15. Grégoire V, Coche E, Cosnard G, Hamoir M, Reychler H (2000) Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56(2):135–150PubMedGoogle Scholar
  16. King AD, Ahuja AT, Teo P, Tse GM, Kew J (2000) Radiation induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma. Clin Radiol 55:684–689PubMedGoogle Scholar
  17. Langendijk JA, Leemans ChR, Buter J, Berkhof J, Slotman BJ (2004) The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A metaanalysis of the published literature. J Clin Oncol 22: 4604–4612PubMedGoogle Scholar
  18. Lee PW, Hung BK, Woo EK, Tai TH, Choi DT (1989) Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry 52:488–492PubMedGoogle Scholar
  19. Ma J, Mai HQ, Hong MH et al. (2001) Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19:1350–1357PubMedGoogle Scholar
  20. Marcial VA, Pajak TF, Mohiuddin M, Cooper JS, Al-Sarraf M, Mowry PA et al. (1990) Concomitant cisplatin chemotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 66:1861–1868PubMedGoogle Scholar
  21. Mould RF, Tai TH (2002) Review article: Nasopharyngeal carcinoma: treatments and outcomes in the 20th century. Br J Radiol 75:307–339PubMedGoogle Scholar
  22. Münter MW, Debus J, Hof H, Nill S, Häring P et al. (2002) Inverse treatment planning and stereotactic intensity modulated therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas. Strahlenther Onkol 178:517–523PubMedGoogle Scholar
  23. Perez CA, Devineni VR, Marcial-Vega V et al. (1992) Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 23(2):271–280PubMedGoogle Scholar
  24. Rossi A, Molinari R, Boracchi P et al. (1988) Adjuvant chemotherapy with vincristine, cyclophosphamide and doxorubicin after radiotherapy in loco-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 6:1401–1410PubMedGoogle Scholar
  25. Sanguineti G, Geara FB, Garden AS et al. (1997) Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 37(5):985–996PubMedGoogle Scholar
  26. Stuschke M, Budach V, Dinges S et al. (1994) Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas. Strahlenther Onkol 170(12):689–699PubMedGoogle Scholar
  27. Wang CC (1990) Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost. Am J Clin Oncol 14(1):5–8Google Scholar
  28. Wolden SL, Zelefsky MJ, Hunt MA et al. (2001) Failure of a 3-D conformal boost to improve radiotherapy of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 49(5): 1229–1234PubMedGoogle Scholar

Tumoren der Nase und der Nasennebenhöhlen

  1. Ang KK, Jiang GL, Frankenthaler RA, Kaanders JH, Garden AS, Delclos L, Peters LJ (1992) Carcinomas of the nasal cavity. Radiother Oncol 24:163–168PubMedGoogle Scholar
  2. Chobe R, McNeese M, Weber R, Fletcher GH (1988) Radiation therapy for carcinoma of the nasal vestibule. Otolaryngol Head Neck Surg 98:67–71PubMedGoogle Scholar
  3. Dulguerov P, Allal AS, Calcaterra TC (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2:683–690PubMedGoogle Scholar
  4. Duthoy W, Boterberg T, Claus F et al. (2005) Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer 104:71–82PubMedGoogle Scholar
  5. Eden BV, Debo RF, Larner JM et al. (1994) Esthesioneuroblastoma. Long-term outcome and patterns of failure – the University of Virginia experience. Cancer 73:2556–2562PubMedGoogle Scholar
  6. Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC (1979) Esthesioneuroblastoma. Cancer 44:1087–1094PubMedGoogle Scholar
  7. Euteneuer S, Sudhoff H, Bernal-Sprekelsen M, Theegarten D, Dazert S (2004) Malignomas of the nasal cavity and the paranasal sinuses: clinical characteristics, therapy and prognosis of different tumor types. Laryngorhinootologie 83:33–39PubMedGoogle Scholar
  8. Foote RL, Morita A, Ebersold MJ et al. (1993) Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 27:835–842PubMedGoogle Scholar
  9. Garden AS, Weber RS, Ang KK, Morrison WH, Matre J, Peters LJ (1994) Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer 73:2563–2569PubMedGoogle Scholar
  10. Hawkins RB, Wynstra JH, Pilepich MV, Fields JN (1988) Carcinoma of the nasal cavity – results of primary and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 15:1129–1133PubMedGoogle Scholar
  11. Jiang GL, Ang KK, Peters LJ, Wendt CD, Oswald MJ, Goepfert H (1991) Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiother Oncol 21:193–200PubMedGoogle Scholar
  12. Jiang GL, Morrison WH, Garden AS, Geara F, Callender D, Goepfert H, Ang KK (1998) Ethmoid sinus carcinomas: natural history and treatment results. Radiother Oncol 49:21–27PubMedGoogle Scholar
  13. Katz TS, Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Villaret DB (2002) Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 24:821–829PubMedGoogle Scholar
  14. Klintenberg C, Olofsson J, Hellquist H, Sokjer H (1984) Adenocarcinoma of the ethmoid sinuses. A review of 28 cases with special reference to wood dust exposure. Cancer 54:482–488PubMedGoogle Scholar
  15. Langendijk JA, Poorter R, Leemans CR, de Bree R, Doornaert P, Slotman BJ (2004) Radiotherapy of squamous cell carcinoma of the nasal vestibule. Int J Radiat Oncol Biol Phys 59:1319–1325PubMedGoogle Scholar
  16. Lewis JS, Castro EB (1972) Cancer of the nasal cavity and paranasal sinuses. J Laryngol Otol 86:255–262PubMedGoogle Scholar
  17. Logue JP, Slevin NJ (1991) Carcinoma of the nasal cavity and paranasal sinuses: an analysis of radical radiotherapy. Clin Oncol (R Coll Radiol) 3Google Scholar
  18. Lohr F, Pirzkall A, Debus J, Rhein B, Hoss A, Schlegel W, Wannenmacher M (2000) Conformal three-dimensional photon radiotherapy for paranasal sinus tumors. Radiother Oncol 56:227–231PubMedGoogle Scholar
  19. Mak AC, van Andel JG, van Woerkom-Eijkenboom WM (1980) Radiation therapy of carcinoma of the nasal vestibule. Eur J Cancer 16:81–85PubMedGoogle Scholar
  20. Mendenhall NP, Parsons JT, Cassisi NJ, Million RR (1984) Carcinoma of the nasal vestibule. Int J Radiat Oncol Biol Phys 10:627–637PubMedGoogle Scholar
  21. Mendenhall WM, Stringer SP, Cassisi NJ, Mendenhall NP (1999) Squamous cell carcinoma of the nasal vestibule. Head Neck 21:385–393PubMedGoogle Scholar
  22. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM (1993) Esthesioneuroblastoma: prognosis and management. Neurosurgery 32:706–714; discussion 714–715PubMedGoogle Scholar
  23. Nazar G, Rodrigo JP, Llorente JL, Baragano L, Suarez C (2004) Prognostic factors of maxillary sinus malignancies. Am J Rhinol 18:233–238PubMedGoogle Scholar
  24. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR (1994 a) Severe dry-eye syndrome following external beam irradiation. Int J Radiat Oncol Biol Phys 30:775–780PubMedGoogle Scholar
  25. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR (1994 b) Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30:765–773PubMedGoogle Scholar
  26. Patel P, Tiwari R, Karim AB, Nauta JJ, Snow GB (1992) Squamous cell carcinoma of the nasal vestibule. J Laryngol Otol 106:332–336PubMedGoogle Scholar
  27. Paulino AC, Marks JE, Bricker P, Melian E, Reddy SP, Emami B (1998) Results of treatment of patients with maxillary sinus carcinoma. Cancer 83:457–465PubMedGoogle Scholar
  28. Sack H, Thesen N (1998) Bestrahlungsplanung. Thieme, StuttgartGoogle Scholar
  29. Strasnick B, Moore DM, Abemayor E, Juillard G, Fu YS (1990) Occult primary tumors. The management of isolated submandibular lymph node metastases. Arch Otolaryngol Head Neck Surg 116:173–176PubMedGoogle Scholar
  30. Van Tassel P, Lee YY (1991) Gd-DTPA enhanced MR for detecting intracranial extension of sinonasal malignancies. J Comput Assist Tomogr 15:387–392PubMedGoogle Scholar
  31. Waldron JN, O’Sullivan B, Warde P, Gullane P, Lui FF, Payne D, Cummings B (1998) Ethmoid sinus cancer: twenty-nine cases managed with primary radiation therapy. Int J Radiat Oncol Biol Phys 41:361–369PubMedGoogle Scholar
  32. Wittekind C, Klimpfinger M, Sobin LH (2005) TNM-Atlas, 5. Auflage. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  33. Wong CS, Cummings BJ, Elhakim T, Briant TD (1986) External irradiation for squamous cell carcinoma of the nasal vestibule. Int J Radiat Oncol Biol Phys 12:1943–194PubMedGoogle Scholar

Mundhöhle

  1. AJCC (1998) Cancer Staging Handbook, 5th edn. Lippincott-Raven, Philadelphia, PennsylvaniaGoogle Scholar
  2. Ash CL (1962) Oral cancer: a twenty-five year study. Am J Roentgenol Radium Ther Nucl Med 87:417–430PubMedGoogle Scholar
  3. Baker SR, Krause CJ (1980) Carcinoma of the lip. Laryngoscope. 90(1):19–27PubMedGoogle Scholar
  4. Bernier J, Cooper JS, Pajak TF et al. (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27(10):843–850PubMedGoogle Scholar
  5. Budach V, Stuschke M, Budach W et al. (2005) Hyperfractionated accelerated chemoradiation with concurrent fluorouracilmitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23(6):1125–1135PubMedGoogle Scholar
  6. Byers RM, Anderson B, Schwarz EA, Fields RS, Meoz R (1984) Treatment of squamous carcinoma of the retromolar trigone. Am J Clin Oncol 7(6):647–652PubMedGoogle Scholar
  7. Byers RM, Newman R, Russell N, Yue A (1981) Results of treatment for squamous carcinoma of the lower gum. Cancer 47(9):2236–2238PubMedGoogle Scholar
  8. Byers RM, O’Brien J, Waxler J (1978) The therapeutic and prognostic implications of nerve invasion in cancer of the lower lip. Int J Radiat Oncol Biol Phys 4(3-4):215–217PubMedGoogle Scholar
  9. Byers RM, Wolf PF, Ballantyne AJ (1988) Rationale for elective modified neck dissection. Head Neck Surg 10(3):160–167PubMedGoogle Scholar
  10. Byers RM (1992) Multiple primary squamous carcinomas of the upper aerodigestive tract. Adv Exp Med Biol 320:27–29PubMedGoogle Scholar
  11. Cady B, Catlin D (1969) Epidermoid carcinoma of the gum. A 20-year survey. Cancer 23(3):551–569PubMedGoogle Scholar
  12. Diaz EM Jr, Holsinger FC, Zuniga ER, Roberts DB, Sorensen DM (2003) Squamous cell carcinoma of the buccal mucosa: one institution’s experience with 119 previously untreated patients. Head Neck 25(4):267–273PubMedGoogle Scholar
  13. Fein DA, Mendenhall WM, Parsons JT, McCarty PJ, Stringer SP, Million RR, Cassisi NJ (1994) Carcinoma of the oral tongue: a comparison of results and complications of treatment with radiotherapy and/or surgery. Head Neck 16(4):358–365PubMedGoogle Scholar
  14. Fietkau R, Grabenbauer GG, Iro H, Muller RG, Farmand M, Atendorf-Hofmann A, Sauer R (1991) Interstitial and percutaneous radiotherapy after limited surgery in carcinoma of the oral cavity. Strahlenther Onkol 167(10):591–598PubMedGoogle Scholar
  15. Fietkau R, Iro H, Grabenbauer GG, Altendorf-Hofmann A, Sauer R (1991) Simultaneous radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck tumors. Strahlenther Onkol 167(12):693–700PubMedGoogle Scholar
  16. Fletcher GH (1972) Elective irradiation of subclinical disease in cancers of the head and neck. Cancer 29(6):1450–1454PubMedGoogle Scholar
  17. Frazell EL, Lucas JC Jr (1962) Cancer of the tongue. Report of the management of 1,554 patients. Cancer 15:1085–1099PubMedGoogle Scholar
  18. Fukano H, Matsuura H, Hasegawa Y, Nakamura S (1997) Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck 19(3):205–210PubMedGoogle Scholar
  19. Gillison ML, Koch WM, Capone RB et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720PubMedGoogle Scholar
  20. Goedert JJ, Cote TR, Virgo P et al. (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351(9119):1833–1839PubMedGoogle Scholar
  21. Hirayama T (1966) An epidemiological study of oral and pharyngeal cancer in Central and South-East Asia. Bull World Health Organ 34(1):41–69PubMedGoogle Scholar
  22. Hong WK, Lippman SM, Itri LM et al. (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323(12):795–801PubMedGoogle Scholar
  23. Jemal A, Murray T, Ward E et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55(1):10–30PubMedGoogle Scholar
  24. Jorgensen K, Elbrond O, Andersen AP (1973) Carcinoma of the lip. A series of 869 patients. Acta Otolaryngol 75(4):312–313PubMedGoogle Scholar
  25. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14(2):467–475PubMedGoogle Scholar
  26. Krolls SO, Hoffman S (1976) Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14,253 cases by age, sex, and race of patients. J Am Dent Assoc 92(3):571–574PubMedGoogle Scholar
  27. Lindberg R (1972) Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29(6):1446–1449PubMedGoogle Scholar
  28. Mackay EN, Sellers AH (1964) A statistical review of carcinoma of the lip. Can Med Assoc J 90:670–672PubMedGoogle Scholar
  29. McGraw WT, Pan JT (1996) Cancer of the gingiva, buccal mucosa, and palate. J Can Dent Assoc 62(2):146–150Google Scholar
  30. Merino OR, Lindberg RD, Fletcher GH (1977) An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40(1):145–151PubMedGoogle Scholar
  31. Million RR, Cassisi NJ, Mancuso AA (1994) Oral cavity. In: Million RR, Cassisi NJ (eds) Management of head and neck cancer: a multidisciplinary approach, 2nd edn. Lippincott, Philadelphia, pp 321–400Google Scholar
  32. Mohit-Tabatabai MA, Sobel HJ, Rush BF, Mashberg A (1986) Relation of thickness of floor of mouth stage I and II cancers to regional metastasis. Am J Surg 152(4):351–353PubMedGoogle Scholar
  33. Mohr C, Bohndorf W, Carstens J et al. (1994) Präoperative Radio-Chemotherapie versus alleinige Radikaloperation fortgeschrittener Mundhöhlenkarzinome. Dtsch Z Mund Kiefer Gesichts Chir 18:5–12Google Scholar
  34. Nag S, Cano ER, Demanes DJ, Puthawala AA, Vikram B (2001) American Brachytherapy Society. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 50(5):1190–1198PubMedGoogle Scholar
  35. Nair MK, Sankaranarayanan R, Padmanabhan TK, Madhu CS (1988) Oral verrucous carcinoma. Treatment with radiotherapy. Cancer 61(3):458–461PubMedGoogle Scholar
  36. Nair MK, Sankaranarayanan R, Padmanabhan TK (1988) Evaluation of the role of radiotherapy in the management of carcinoma of the buccal mucosa. Cancer 61(7):1326–1331PubMedGoogle Scholar
  37. Nandapalan V, Roland NJ, Helliwell TR, Williams EM, Hamilton JW, Jones AS (1998) Mucosal melanoma of the head and neck. Clin Otolaryngol Allied Sci 23(2):107–116PubMedGoogle Scholar
  38. O’Brien CJ, Lahr CJ, Soong SJ, Gandour MJ, Jones JM, Urist MM, Maddox WA (1986) Surgical treatment of early-stage carcinoma of the oral tongue – wound adjuvant treatment be beneficial? Head Neck Surg 8(6):401–408PubMedGoogle Scholar
  39. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355(9208):949–955PubMedGoogle Scholar
  40. Pitman KT, Dean R (2002) Management of the clinically negative (N0) neck. Curr Oncol Rep 4(1):81–86PubMedGoogle Scholar
  41. Pop LA, Eijkenboom WM, de Boer MF et al. (1989) Evaluation of treatment results of squamous cell carcinoma of the buccal mucosa. Int J Radiat Oncol Biol Phys 16(2):483–487PubMedGoogle Scholar
  42. Robbins KT (1999) Integrating radiological criteria into the classification of cervical lymph node disease. Arch Otolaryngol Head Neck Surg 125(4):385–387PubMedGoogle Scholar
  43. Rosenthal DI, Ang KK (2004) Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma. Semin Radiat Oncol 14(2):153–166PubMedGoogle Scholar
  44. Rumboldt Z, Gordon L, Bonsall R, Ackermann S (2006) Imaging in head and neck cancer. Curr Treat Options Oncol 7(1):23–34PubMedGoogle Scholar
  45. Scholl P, Byers RM, Batsakis JG, Wolf P, Santini H (1986) Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications. Am J Surg 152(4):354–360PubMedGoogle Scholar
  46. Shasha D, Harrison LB (1998) Elective irradiation of the N0 neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Clin North Am 31(5):803–813PubMedGoogle Scholar
  47. Shklar G (1984) The oral cavity, jaws, and salivary glands. In: Robbins S (ed) Pathologic Basis of Disease, 3rd ed. WB Saunders, Philadelphia, pp 783–784Google Scholar
  48. Shopland DR, Pechacek TF, Cullen JW (1990) Toward a tobacco-free society. Semin Oncol 17(4):402–412PubMedGoogle Scholar
  49. Silverman S Jr, Gorsky M, Lozada-Nur F (1985) A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 60(1):30–34PubMedGoogle Scholar
  50. Staar S, Rudat V, Stuetzer H et al. (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy – results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50(5):1161–1171PubMedGoogle Scholar
  51. Strnad V, Melzner W, Geiger M et al. (2005) Role of Interstitial PDR Brachytherapy in the Treatment of Oral and Oropharyngeal Cancer: A Single-Institute Experience of 236 Patients. Strahlenther Onkol 181(12):762–767PubMedGoogle Scholar
  52. Strnad V (2004) Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy. Strahlenther Onkol 180(11):710–717PubMedGoogle Scholar
  53. Taybos G (2003) Oral changes associated with tobacco use. Am J Med Sci 326(4):179–182PubMedGoogle Scholar
  54. Teichgraeber JF, Larson DL (1988) Some oncologic considerations in the treatment of lip cancer. Otolaryngol Head Neck Surg 98(6):589–592PubMedGoogle Scholar
  55. Visser AG, van den Aardweg GJ, Levendag PC (1996) Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments. Int J Radiat Oncol Biol Phys 34(2):497–505PubMedGoogle Scholar
  56. Wang CC (1992) Oral cavity. In: Perez CA, Brady LW (eds) Principles and Practice of Radiation Oncology, 2nd ed. JB Lippincott, Philadelphia, pp 672–673Google Scholar
  57. Wang CC (1983) Radiation Therapy for Head and Neck Neoplasms: Indications, Techniques and Results. Wright-PSG, Littleton, MAGoogle Scholar
  58. Wendt TG, Grabenbauer GG, Rodel CM et al. (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16(4):1318–1324PubMedGoogle Scholar
  59. Yorozu A, Sykes AJ, Slevin NJ (2001) Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases. Oral Oncol 37(6):493–497PubMedGoogle Scholar
  60. Zelefsky MJ, Harrison LB, Fass DE, Armstrong J, Spiro RH, Shah JP, Strong EW (1990) Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome. Head Neck 12(6):470–475PubMedGoogle Scholar

Oropharynxkarzinom

  1. Ang KK, Garden AS (2006) Radiotherapy of head and neck cancers – indications and techniques, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, BaltimoreGoogle Scholar
  2. Ang KK, Trotti A, Brown BW et al. (2001) Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:571–578PubMedGoogle Scholar
  3. Ang KK, Harris J Wheeler R et al. (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. Jul 1, 363(1):24–35PubMedGoogle Scholar
  4. Ang KK, Zhang Q, Rosenthal DIet al. (2011) A Randomized Phase III Trial (RTOG 0522) of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III-IV Head and Neck Squamous Cell Carcinomas (HNC). Proc ASCOGoogle Scholar
  5. Bernier J, Domenge C, Ozsahin M et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952PubMedGoogle Scholar
  6. Bonner JA, Giralt J, Harari PM et al. (2004) Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck; A phase III study of high dose radiation therapy with or without cetuiximab. ASCO Annual Meeting, New OrleansGoogle Scholar
  7. Bonner JA, Harari PM, Giralt J et al. (2006) Radiotherapy plus cetuiximab for squamous-cell carcinoma of the head and neck. New Engl J Med. Feb 9; 354(6):567–578Google Scholar
  8. Bonner JA, Harari PM, Giralt J et al. (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. Jan;11(1):21–28PubMedGoogle Scholar
  9. Bratengeier K, Pfreundner L, Flentje M (2000) Radiation techniques for head and neck tumors. Radiother Oncol 56:209–220PubMedGoogle Scholar
  10. Brizel DM, Albers ME, Fisher SR et al. (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798–1804PubMedGoogle Scholar
  11. Brizel DM, Wasserman TH, Henke M et al. (2000) Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339–3345PubMedGoogle Scholar
  12. Browman GP, Wong G, Hodson I et al. (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. Jan 21;328(3):159–163PubMedGoogle Scholar
  13. Budach V, Stuschke M, Budach W et al. (2005) Hyperfractionated accelerated chemoradiation with concurrent fluorouracilmitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective randomized trial. J Clin Oncol 23:1125–1135PubMedGoogle Scholar
  14. Cooper JS, Pajak TF, Forastiere AA et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944PubMedGoogle Scholar
  15. Dawson LA, Myers LL, Bradford CR et al. (2001) Conformal reirradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:377–385PubMedGoogle Scholar
  16. de Arruda FF, Puri DR, Zhung J et al. (2006) Intensitymodulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64:363–373PubMedGoogle Scholar
  17. Denis F, Garaud P, Bardet E et al. (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69–76PubMedGoogle Scholar
  18. Dische S, Saunders M, Barrett A et al. (1997) A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44:123–136PubMedGoogle Scholar
  19. Friedrich RE, Krull A, Schwarz R et al. (1997) Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery. Strahlenther Onkol 173:507–512PubMedGoogle Scholar
  20. Fu KK, Pajak TF, Trotti A et al. (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16PubMedGoogle Scholar
  21. Henke M, Laszig R, Rube C et al. (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362:1255–1260PubMedGoogle Scholar
  22. Horiot JC, Bontemps P, van den Bogaert W et al. (1997) Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44:111–121PubMedGoogle Scholar
  23. Horiot JC, Le Fur R, N’Guyen T et al. (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25: 231–241PubMedGoogle Scholar
  24. Lindberg R (1972) Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29:1446–1449PubMedGoogle Scholar
  25. Munter MW, Karger CP, Hoffner SG et al. (2004) Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 58:175–184PubMedGoogle Scholar
  26. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A’Hern RP, Sydenham MA, Emson M, Hall E; PARSPORT trial management group (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. Feb;12(2):127–136PubMedGoogle Scholar
  27. Parliament MB, Scrimger RA, Anderson SG et al. (2004) Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 58:663–673PubMedGoogle Scholar
  28. Parsons JT, Mendenhall WM, Stringer SP et al. (2002) Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 94:2967–2980PubMedGoogle Scholar
  29. Peters LJ, Goepfert H, Ang KK et al. (1993) Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26:3–11PubMedGoogle Scholar
  30. Pignon JP, Bourhis J, Domenge C et al. (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949–955PubMedGoogle Scholar
  31. Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol. Jul;92(1):4–14Google Scholar
  32. Rodriguez J, Point D, Brunin F et al. (1996) Surgery of the oropharynx after radiotherapy. Bull Cancer Radiother 83:24–30PubMedGoogle Scholar
  33. Rudat V, Meyer J, Momm F et al. (2000) Protective effect of amifostine on dental health after radiotherapy of the head and neck. Int J Radiat Oncol Biol Phys 48:1339–1343PubMedGoogle Scholar
  34. Staar S, Rudat V, Stuetzer H et al. (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy – results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:1161–1171PubMedGoogle Scholar
  35. Tobias JS, Monson K, Gupta N, Macdougall H, Glaholm J, Hutchison I, Kadalayil L, Hackshaw A UK Head and Neck Cancer Trialists’ Group (2010) Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial. Lancet Oncol. Jan;11(1):66–74Google Scholar
  36. Wiggenraad R, Mast M, van Santvoort J et al. (2005) ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 181:673–682PubMedGoogle Scholar
  37. Wittekind CH, Meyer HJ (2010) TNM Klassifikation maligner Tumoren. 7. Auflage. Wiley-VCH, WeinheimGoogle Scholar

Larynx- und Hypopharynxkarzinome

  1. Bernier J, Domenge C, Ozsahin M et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952PubMedGoogle Scholar
  2. Bocca E, Pignataro O, Oldini C (1983) Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol 92:14–18PubMedGoogle Scholar
  3. Cooper JS, Pajak TF, Forastiere AA et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944PubMedGoogle Scholar
  4. Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690Google Scholar
  5. Fletcher GH, Goepfert H (1980) Larynx and hypopharynx. In: Fletcher GH (ed) Textbook of Radiotherapy, 3rd ed. Lea & Febiger, Philadelphia, S 330Google Scholar
  6. Forastiere AA, Goepfert H, Maor M et al. (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098PubMedGoogle Scholar
  7. Forastiere AA, Zhang Q, Weber RS et al. (2013) Ensley JF Cooper JS. Long-term results of rtog 91–11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology;31:845–852Google Scholar
  8. Frank JL, Garb JL, Kay S et al. (1994) Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx. Am J Surg 168:476–480PubMedGoogle Scholar
  9. Garden AS, Morrison MD, Ang KK, Peters LJ (1995) Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparsion of two fractionation schedules. Int J Radiat Oncol Biol Phys 31:493–502PubMedGoogle Scholar
  10. Goepfert H, Jesse RH, Fletcher GH, Hamberger A (1975) Optimal treatment for the technically resectable squamous cell carcinoma of the supraglottic larynx. Laryngoscope 85: 14–32PubMedGoogle Scholar
  11. Harrison LB, Solomon B, Miller S, Fass DE, Armstrong J, Sessions RB (1990) Prospective computer-assisted voice analysis for patients with early stage glottic cancer: a preliminary report of the functional result of laryngeal irradiation. Int J Radiat Oncol Biol Phys 19:123–127PubMedGoogle Scholar
  12. Harwood AR, Hawkins NV, Rider WD, Bryce DP (1979) Radiotherapy of early glottic cancer – I. Int J Radiat Oncol Biol Phys 5:473–476PubMedGoogle Scholar
  13. Harwood AR, Beale FA, Cummings BJ, Keane TJ, Rider WD (1981) T2 glottic cancer: an analysis of dose-time-volume factors. Int J Radiat Oncol Biol Phys 7:1501–1505PubMedGoogle Scholar
  14. Hehr T, Classen J, Schreck U, Glocker S, Koitschev A, Bamberg M, Budach W (2002) Selective lymph node dissection following hyperfractionated accelerated radio-(chemo-)the-rapy for advanced head and neck cancer. Strahlenther Onkol 178:363–368PubMedGoogle Scholar
  15. Howell-Burke D, Peters LJ, Goepfert H, Oswald MJ (1990) T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg 116:830–835PubMedGoogle Scholar
  16. Kelly MD, Hahn SS, Spaulding CA, Kersh CR, Constable WC, Cantrell RW (1989) Definitive radiotherapy in the management of stage I and II carcinomas of the glottis. Ann Otol Rhinol Laryngol 98:235–239PubMedGoogle Scholar
  17. Le QT, Fu KK, Kroll S et al. (1997) Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 39:115–126PubMedGoogle Scholar
  18. Lindberg R (1972) Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29:1446–1449PubMedGoogle Scholar
  19. Lustig RA, MacLean CJ, Hanks GE, Kramer S (1984) The Patterns of Care Outcome Studies: results of the National practice in carcinoma of the larynx. Int J Radiat Oncol Biol Phys 10:2357–2362PubMedGoogle Scholar
  20. McGuirt WF, Blalock D, Koufman JA, Feehs RS, Hilliard AJ, Greven K, Randall M (1994) Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch Otolaryngol Head Neck Surg 120:951–955PubMedGoogle Scholar
  21. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR (1993) Radiotherapy alone or combined with neck dissection for T1-T2 carcinoma of the pyriform sinus: an alternative to conservation surgery. Int J Radiat Oncol Biol Phys 27:1017–1027PubMedGoogle Scholar
  22. Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP, Cassisi NJ (1996) Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 18:24–35PubMedGoogle Scholar
  23. Million RR, Cassisi NJ, Mancuso AA (1994) Larynx. In: Million RR, Cassisi NJ (eds) Management of Head and Neck Cancer: A Multidisciplinary Approach, 2nd ed. Lippincott, Philadelphia, pp 431–497Google Scholar
  24. Mittal B, Rao DV, Marks JE, Ogura JH (1983) Comparative cost analysis of hemilaryngectomy and irradiation for early glottic carcinoma. Int J Radiat Oncol Biol Phys 9:407–408PubMedGoogle Scholar
  25. Morrison MD (1988) Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol Head Neck Surg 99:370–373PubMedGoogle Scholar
  26. Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949–955PubMedGoogle Scholar
  27. Schwaab G, Mamelle G, Lartigau E, Parise O Jr, Wibault P, Luboinski B (1994) Surgical salvage treatment of T1/T2 glottic carcinoma after failure of radiotherapy. Am J Surg 168:474–475PubMedGoogle Scholar
  28. Shirinian MH, Weber RS, Lippman SM et al. (1994) Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Head Neck 16:39–44PubMedGoogle Scholar
  29. Staar S, Rudat V, Stuetzer H et al. (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy – results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50:1161–1171PubMedGoogle Scholar
  30. Vandenbrouck C, Eschwege F, De la Rochefordiere A et al. (1987) Squamous cell carcinoma of the pyriform sinus: retrospective study of 351 cases treated at the Institut Gustave-Roussy. Head Neck Surg 10:4–13PubMedGoogle Scholar
  31. Wang CC (1997b) Carcinomas of the larynx. In: Radiation therapy for head and neck neoplasms. Wiley-Liss, New York, p 221Google Scholar
  32. Wang CC (1997 a) Carcinomas of the hypopharynx. In: Radiation therapy for head and neck neoplasms. Wiley-Liss, New York, p 221Google Scholar
  33. Wang CC, Nakfoor BM, Spiro IJ, Martins P (1997) Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results. Cancer J Sci Am 3:88–91PubMedGoogle Scholar
  34. Ward PH, Hanson DG (1988) Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 98: 1195–1199PubMedGoogle Scholar
  35. Wydner EL, Bross IJ, Day E (1956) Epidemiological approach to the etiology of cancer of the larynx. JAMA 160:1384Google Scholar

Tumoren der Speicheldrüsen

  1. Airoldi M, Fornari G, Pedani F et al. (2000) Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 20(5C):3781–3783PubMedGoogle Scholar
  2. Airoldi M, Gabriele AM, Gabriele P et al. (2001) Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma. Tumori 87(1): 14–17PubMedGoogle Scholar
  3. Armstrong JG, Harrison LB, Spiro RH et al. (1990) Malignant tumors of major salivary gland origin: a matched-pair analysis of the role of combined surgery and postoperative radiation therapy. Arch Otorhinolaryngol Head Neck Surg 116:290–293Google Scholar
  4. Armstrong JG, Harrison LB, Thaler HT et al. (1992) The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69(3):615–619PubMedGoogle Scholar
  5. Avery CM, Moody AB, McKinna FE et al. (2000) Combined treatment of adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg 29(4):277–279PubMedGoogle Scholar
  6. Barnes L, Eveson JW, Reichart P et al. (2005) Eds: World Health Organization Classification of Tumours – Pathology and genetic of Head and Neck Tumours. IARC Press, Lyon.Google Scholar
  7. Batsakis JG, Chinn E, Regezi JA et al. (1978) The pathology of head and neck tumors: salivary glands, part 2. Head Neck Surg 1(2):167–180PubMedGoogle Scholar
  8. Batsakis JG, Regezi JA (1979) The pathology of head and neck tumors: salivary glands, part 4. Head Neck Surg 1(4): 340–349PubMedGoogle Scholar
  9. Batsakis JG, Regezi JA, Bloch D (1979) The pathology of head and neck tumors: salivary glands, part 3. Head Neck Surg 1(3):260–273PubMedGoogle Scholar
  10. Batsakis JG, Luna MA (1990) Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol 99(10):835–838PubMedGoogle Scholar
  11. Batsakis JG, Luna MA, el Naggar AK (1990) Histopathologic grading of salivary gland neoplasms: II. Acinic cell carcinomas. Ann Otol Rhinol Laryngol 99(11):929–933PubMedGoogle Scholar
  12. Batterman JJ, Breur K, Hart GA et al. (1981) Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays. Eur J Cancer 17:539–548Google Scholar
  13. Belsky JL, Tachikawa K, Cihak KW et al. (1972) Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957–1970. JAMA 219:864–868PubMedGoogle Scholar
  14. Borthne A, Kjellevold K, Kaalhus O et al. (1986) Salivary gland malignant neoplasms: treatment and prognosis. Int J Radiat Oncol Biol Phys 12(5):747–754PubMedGoogle Scholar
  15. Bragg CM, Conway J, Robinson MH (2002) The role of intensity-modulated radiotherapy in the treatment of parotid tumors. Int J Radiat Oncol Biol Phys 52(3):729–738PubMedGoogle Scholar
  16. Buchholz TA, Laramore GE, Griffin BR et al. (1992) The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms. Cancer 69(11): 2779–2788PubMedGoogle Scholar
  17. Catterall M, Errington RD (1987) The implications of improved treatment of malignant salivary gland tumors by fast neutron radiotherapy. Int J Radiat Oncol Biol Phys 13(9): 1313–1318PubMedGoogle Scholar
  18. Chen AM, Garcia J, Lee NY et al. (2007) Patterns of nodal relapse after sugery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 67(4):988–994PubMedGoogle Scholar
  19. Coiffier T, Aidan D, Vilde F et al. (1996) Les tumeurs malignes de la parotide. A propos de 60 cas. Ann Otolaryngol Chir Cervicofac 113(7–8):419–424PubMedGoogle Scholar
  20. Cowie VJ, Pointon RC (1984) Adenoid cystic carcinoma of the salivary glands. Clin Radiol 35(4):331–333PubMedGoogle Scholar
  21. Creagan E, Woods J, Rubin J (1988) Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck. Cancer 62: 2313–2319PubMedGoogle Scholar
  22. Dawson AK, Orr JA (1985) Long-term results of local excision and radiotherapy in pleomorphic adenoma of the parotid. Int J Radiat Oncol Biol Phys 11(3):451–455PubMedGoogle Scholar
  23. Dodd RL, Slevin NJ (2006) Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42(8):759–769PubMedGoogle Scholar
  24. Douglas JG, Laramore GE, Austin-Seymour M et al. (2000) Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiat Oncol Biol Phys 46(3):551–557PubMedGoogle Scholar
  25. Dreyfuss AI, Clark JR, Fallon BG et al. (1987) Cyclophosphamid, doxorubicin, and cisplatin combination chemotherapy for advanced carcinoma of salivary gland origin. Cancer 60:2869–2872PubMedGoogle Scholar
  26. Eapen LJ, Gerig LH, Catton GE et al. (1988) Impact of local radiation in the management of salivary gland carcinomas. Head Neck Surg 10(4):239–245PubMedGoogle Scholar
  27. Ellis ER, Million RR, Mendenhall WM et al. (1988) The use of radiation therapy in the management of minor salivary gland tumors. Int J Radiat Oncol Biol Phys 15:613–617PubMedGoogle Scholar
  28. Federspil PA, Constantinidis J, Karapantzos I et al. (2001) Acinic cell carcinomas of the parotid gland. A retrospective analysis. HNO 49(10):825–830PubMedGoogle Scholar
  29. Feldmann HJ, Budach V, Budach W et al. (1991) Postoperative radiotherapy of salivary gland tumors. Prognostic factors and treatment results. Strahlenther Onkol 167(5):261–266PubMedGoogle Scholar
  30. Fitzpatrick PJ, Theriault C (1986) Malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 12(10):1743–1747PubMedGoogle Scholar
  31. Frankenthaler RA, Luna MA, Lee SS et al. (1991) Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg 117(11):1251–1256PubMedGoogle Scholar
  32. Frankenthaler RA, El-Naggar AK, Ordonez NG et al. (1994) High correlation with survival of proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of the parotid gland. Otolaryngol Head Neck Surg 11:460–466Google Scholar
  33. Gallo O, Santucci M, Calzorlari A et al. (1994) Epstein-Barr virus (EBV) infection and undifferentiated carcinoma of the parotid gland in Caucasian patients. Acta Otolaryngol 114:572–575PubMedGoogle Scholar
  34. Garden AS, Weber RS, Morrison WH et al. (1995) The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 32(3):619–626PubMedGoogle Scholar
  35. Garden AS, el Naggar AK, Morrison WH et al. (1997) Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 37(1):79–85PubMedGoogle Scholar
  36. Glanzmann C (1990) Langzeit-Resultate nach postoperativer und primärer Radiotherapie von Karzinomen der Kopfspeicheldrüsen: Bedeutung von Dosis und Zielvolumen. Strahlenther Onkol 166(3):183–189PubMedGoogle Scholar
  37. Guillamondegui OM, Byers RM, Luna MA et al. (1975) Aggressive surgery in the treatment for cancer: the role of adjunctive postoperative radiotherapy. Am J Roentgenol 123: 49–54Google Scholar
  38. Haubrich J, Miehlke A (1978) Zur Therapie von Parotistumoren. Chirurg 49:114–116PubMedGoogle Scholar
  39. Hatta C, Terada T, Okita J et al. (2003) Clinicopathological study of undifferentiated carcinoma of the parotid gland. Auris Nasus Larynx 30(3):273–277PubMedGoogle Scholar
  40. Huber PE, Debus J, Latz D et al. (2001) Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol 59(2):161–167PubMedGoogle Scholar
  41. Johns ME, Kaplan MJ (1987) Surgical therapy of tumors of the salivary glands. In: Thawley S, Panje WR: Comprehensive management of head and neck tumors. Saunders 2: 1105–1138Google Scholar
  42. Johns ME, Goldsmith MM (1989) Incidence, diagnosis, and classification of salivary gland tumors. Part 1. Oncology (Huntington) 3(2):47–56Google Scholar
  43. Kaplan MJ, Johns ME, Cantrell RW (1986) Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 95(2):165–170PubMedGoogle Scholar
  44. Kim KH, Chung PS, Rhee CS et al. (1994) The manifestation of proliferating cell nuclear antigen in adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 120:1221–1225PubMedGoogle Scholar
  45. Krüll A, Schwarz R, Engenhart R et al. (1996) European results in neutron therapy of malignant salivary gland tumors. Bull Cancer Radiother 83 (Suppl):125–129Google Scholar
  46. Krüll A, Schwarz R, Brackrock S et al. (1998) Neutron therapy in malignant salivary gland tumors: results at European centers. Rec Res Cancer Res 150:88–99Google Scholar
  47. Laramore GE, Krall JM, Griffin TW et al. (1993) Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 27(2):235–240PubMedGoogle Scholar
  48. Le Q-T, Birdwell S, Terris DJ et al. (1999) Postoperative irradiation of minor salivary gland malignancies of the head and neck. Radiother Oncol 52:165–171PubMedGoogle Scholar
  49. Lopes MA, Santos GC, Kowalski LP (1998) Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head and Neck 20(8):699–706PubMedGoogle Scholar
  50. Luna MA, Batsakis JG, el-Naggar AK (1991) Salivary gland tumors in children. Ann Otol Rhinol Laryngol 100(10): 869–871PubMedGoogle Scholar
  51. Maciejewski A, Szymczyk C, Wierzgonn J. (2002) Outcome of surgery for adenoid cystic carcinoma of head and neck region. J Craniomaxillofac Surg 30(1):59–61PubMedGoogle Scholar
  52. Matsuba HM, Thawley SE, Devineni VR et al. (1985) High-grade malignancies of the parotid gland: effective use of planned combined surgery and irradiation. Laryngoscope 95(9): 1059–1063PubMedGoogle Scholar
  53. Miglianico L, Eschwege F, Marandas P et al. (1987) Cervico-facial adenoid cystic carcinoma: study of 102 cases. Influence of radiation therapy. Int J Radiat Oncol Biol Phys 13(5):673–678PubMedGoogle Scholar
  54. North CA, Lee DJ, Piantadosi S et al. (1990) Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 18(6):1319–1326PubMedGoogle Scholar
  55. Nutting CM, Rowbottom CG, Cosgrove VP et al. (2001) Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques. Radiother Oncol 60(2):163–172PubMedGoogle Scholar
  56. Parsons JT, Mendenhall WM, Stringer SP et al. (1996) Management of minor salivary gland carcinomas. Int J Radiat Oncol Biol Phys 35(3):443–454PubMedGoogle Scholar
  57. Pötter R, Prott FJ, Micke O et al. (1999) Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands. Strahlenther Onkol 175 (Suppl 2):65–68PubMedGoogle Scholar
  58. Pommier P, Liebsch NJ, Deschler DG, et al. (2006) Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 132(11):1242–1249PubMedGoogle Scholar
  59. Press MF, Pike MC, Hung G et al. (1994) Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 54(21):5675–5682PubMedGoogle Scholar
  60. Renehan AG, Gleave EN, Slevin NJ et al. (1999) Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer 80(8):1296–1300PubMedGoogle Scholar
  61. Santucci M, Bondi R (1989) New prognostic criterion in adenoid cystic carcinoma of salivary gland origin. Am J Clin Pathol 91(2):132–136PubMedGoogle Scholar
  62. Saroja KR, Mansell J, Hendrickson FR et al. (1987) An update on malignant salivary gland tumors treated with neutrons at Fermilab. Int J Radiat Oncol Biol Phys 13(9):1319–1325PubMedGoogle Scholar
  63. Sartoretti-Schefer S, Sartoretti C, Wichmann W et al. (1995) Anatomie und Pathologie der Glandula parotis. Korrelation mit der Magnetresonanztomographie (MRT). Radiologe 35(11):848–865PubMedGoogle Scholar
  64. Schneider AB, Favus MJ, Stachura ME et al. (1977) Salivary gland neoplasms as a late consequence of head and neck irradiation. Ann Intern Med 87:160PubMedGoogle Scholar
  65. Schulz-Ertner D, Didinger B, Nikoghosyan A et al. (2003) Optimization of radiation therapy for locally advanced adenoid cystic carcinomas with infiltration of the skull base using intensity modulated radiation therapy (IMRT) and a carbon ion boost. Strahlenther Onkol 179:345–351PubMedGoogle Scholar
  66. Schulz-Ertner D, Nikoghosyan A, Didinger B et al. (2005) Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 104(2):338–344PubMedGoogle Scholar
  67. Seifert G, Brocheriou C, Cardesa A et al. (1990) WHO International Histological Classification of Tumours. Tentative histological classification of salivary gland tumours. Pathol Res Pract 186(5):555–581PubMedGoogle Scholar
  68. Seifert G, Sobin LH (1992) The World Health Organization’s Histological Classification of Salivary Gland Tumours. A commentary on the second edition. Cancer 70(2):379–385PubMedGoogle Scholar
  69. Simpson JR, Thawley SE, Matsuba HM (1984) Adenoid cystic salivary gland carcinoma: treatment with irradiation and surgery. Radiology 151(2):509–512PubMedGoogle Scholar
  70. Spiro RH, Huvos AG, Strong EW (1978) Acinic cell carcinoma of salivary origin. A clinicopathologic study of 67 cases. Cancer 41:924–935PubMedGoogle Scholar
  71. Spiro RH (1986) Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg 8(3):177–184PubMedGoogle Scholar
  72. Spiro RH (1997) Distant metastasis in adenoid cystic carcinoma of salivary origin. American Journal of Surgery 174(5):495–498PubMedGoogle Scholar
  73. Spiro RH, Huvos AG (1992) Stage means more than grade in adenoid cystic carcinoma. Am J Surg 164(6):623–628PubMedGoogle Scholar
  74. Spitz MR, Fueger JJ, Goepfert H et al. (1990) Salivary gland cancer. A case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg 116(10):1163–1166PubMedGoogle Scholar
  75. Stennert E, Kisner D, Jungehuelsing M et al. (2003) High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 129(7):720–723PubMedGoogle Scholar
  76. Stern SJ, Suen JY (1993) Salivary gland tumors. Curr Opin Oncol 5(3):518–525PubMedGoogle Scholar
  77. Takeichi N, Hirose F, Yamamota H et al. (1983) Salivary gland tumors in atomic bomb survivors, Hiroshima, Japan: II. Pathologic study and supplementary epidemiologic observations. Cancer 52:377–385PubMedGoogle Scholar
  78. Teshima T, Inoue T, Ideda H et al. (1993) Radiation therapy for carcinoma of the major salivary glands. Results of conventional irradiation technique. Strahlenther Onkol 169(8):486–491PubMedGoogle Scholar
  79. Theriault C, Fitzpatrick PJ (1986) Malignant parotid tumors. Prognostic factors and optimum treatment. Am J Clin Oncol 9(6):510–516PubMedGoogle Scholar
  80. Wittekind C, Meyer H-J, Bootz F (Hrsg) (2002) TNM-Klassifikation maligner Tumoren, 6. Aufl. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  81. Vikram B, Sttron EW, Shah JP et al. (1984) Radiation therapy in adenoid-cystic carcinoma. Int J Radiat Oncol Biol Phys 10(2):221–223PubMedGoogle Scholar
  82. Witten J, Hybert F, Sand Hansen S (1990) Treatment of malignant tumors in the parotid glands. Cancer 65:2515–2520PubMedGoogle Scholar
  83. Yu GY, Ma DQ (1987) Carcinoma of the salivary gland. A clinicopathologic study of 405 cases. Semin Surg Oncol 3: 240–244PubMedGoogle Scholar

CUP-Syndrom

  1. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12:1272–1280PubMedGoogle Scholar
  2. Argiris A, Smith SM, Stenson K, Mittal BB, Pelzer HJ, Kies MS, Haraf DJ, Vokes EE (2003) Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol. Aug;14(8):1306–1311PubMedGoogle Scholar
  3. Balana C, Manzano JL, Moreno I et al. (2003) A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site. Ann Oncol 14:1425–1429PubMedGoogle Scholar
  4. Bertz J, Hentschel S, Hundsdörfer G et al. (2004) Krebs in Deutschland, 4. überarbeitete, aktualisierte Ausgabe edit. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland in Zusammenarbeit mit dem Robert-Koch-Institut, SaarbrückenGoogle Scholar
  5. Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB (2000) Cervical lymph node metastases from unknown primary tumors. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 55:121–129PubMedGoogle Scholar
  6. Hansen HH, Daugaard G (2001) Management of carcinoma of unknown primary site (CUP), any changes? Ann Oncol 12: 431–432PubMedGoogle Scholar
  7. Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L (1999) 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumors (UPT). Eur J Cancer 35:1076–1082PubMedGoogle Scholar
  8. Nieder C, Gregoire V, Ang KK (2001) Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 50: 727–733PubMedGoogle Scholar
  9. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA (2003) Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39:1990–2005PubMedGoogle Scholar
  10. Pouessel D, Culine S, Becht C et al. (2004) Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site. Cancer 100:1257–1261PubMedGoogle Scholar
  11. Reske SN, Dankerl A, Glatting G, Mottaghy FM, Blumstein NM (2004) Significance of PET for ENT-tumors. Laryngorhinootologie 83:391–406; quiz 407–410PubMedGoogle Scholar
  12. Saghatchian M, Fizazi K, Borel C, Ducreux M, Ruffie P, Le Chevalier T, Theodore C (2001) Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation – results of a prospective study. Ann Oncol 12:535–540PubMedGoogle Scholar
  13. Varadhachary GR, Abbruzzese JL, Lenzi R (2004) Diagnostic strategies for unknown primary cancer. Cancer 100: 1776–1785PubMedGoogle Scholar
  14. Werner JA, Dunne AA (2001) Value of neck dissection in patients with squamous cell carcinoma of unknown primary. Onkologie 24:16–20PubMedGoogle Scholar

Schilddrüsenkarzinom

  1. Biermann M, Pixberg MK, Schuck A et al. (2003) Multicenter study differentiated thyroid carcinoma (MSDS). Diminished acceptance of adjuvant external beam radiotherapy. Nuklearmedizin 42:244–250PubMedGoogle Scholar
  2. Brierley J, Tsang R, Simpson WJ et al. (1996) Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6:305–310PubMedGoogle Scholar
  3. Hundahl SA, Fleming ID, Fremgen AM et al. (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U. S., 1985–1995 [see comments]. Cancer 83:2638–2648PubMedGoogle Scholar
  4. Machens A, Hinze R, Lautenschlager C et al. (2001) Extended surgery and early postoperative radiotherapy for undifferentiated thyroid carcinoma. Thyroid 11:373–380PubMedGoogle Scholar
  5. Nutting CM, Convery DJ, Cosgrove VP et al. (2001) Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 60:173–180PubMedGoogle Scholar
  6. Passler C, Scheuba C, Prager G et al. (1999) Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg 384:284–293PubMedGoogle Scholar
  7. Reinhardt M, Guttenberger R, Slanina J et al. (1995) Indications for percutaneous radiotherapy in carcinoma of the thyroid gland. Freiburg consensus. Radiologe 35:535–539PubMedGoogle Scholar
  8. Ron E, Lubin JH, Shore RE et al. (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259–277PubMedGoogle Scholar
  9. Sautter-Bihl ML, Raub J, Hetzel-Sesterheim M et al. (2001) Differentiated thyroid cancer: prognostic factors and influence of treatment on the outcome in 441 patients. Strahlenther Onkol 177:125–131PubMedGoogle Scholar
  10. Schuck A, Biermann M, Pixberg MK et al. (2003) Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS). Strahlenther Onkol 179:832–839PubMedGoogle Scholar
  11. Simon D, Korber C, Krausch M et al. (2002) Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 29:775–782PubMedGoogle Scholar
  12. Simpson WJ, Panzarella T, Carruthers JS et al. (1988) Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14:1063–1075PubMedGoogle Scholar
  13. Tennvall J, Lundell G, Hallquist A et al. (1994) Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group. Cancer 74: 1348–1354PubMedGoogle Scholar
  14. Tennvall J, Lundell G, Wahlberg P et al. (2002) Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 86:1848–1853PubMedGoogle Scholar
  15. Wiseman SM, Loree TR, Rigual NR et al. (2003) Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 25:662–670PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • D. Thönnessen
    • 1
  • H. Hof
    • 2
  • R. Krempien
    • 3
  • M. W. Münter
    • 4
  • M. Bischof
    • 5
  • K. K. Herfarth
    • 5
  • D. Schulz-Ertner
    • 6
  • K. Fleckenstein
    • 7
  1. 1.Gemeinschaftspraxis für StrahlentherapieBaden-BadenDeutschland
  2. 2.Strahlentherapie Rhein/PfalzNeustadt an der WeinstraßeDeutschland
  3. 3.Helios Kliniken GmbH, Klinik für StrahlentherapieBerlin-BuchDeutschland
  4. 4.Klinikum Stuttgart – Katharinenhospital (KH)Radioonkologie und StrahlentherapieStuttgartDeutschland
  5. 5.Abteilung für Radioonkologie und StrahlentherapieRadiologische KlinikHeidelbergDeutschland
  6. 6.Abt. für Radioonkologie und StrahlentherapieMarkus KrankenhausFrankfurt am MainDeutschland
  7. 7.Klinik für Strahlentherapie und RadioonkologieUniversitätsklinikum MannheimMannheimDeutschland

Personalised recommendations